Title:
SALT OF AMINOPYRIMIDINE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/125275
Kind Code:
A1
Abstract:
Provided are a salt of an aminopyrimidine compound and a use thereof. Specifically, provided are a salt of (S)-2-(1-((6-amino-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrimidin-4-yl)amino)ethyl)-5-(3-hydroxyprop-1-yn-1-yl)-3-phenylquinazolin-4(3H)-one and a pharmaceutical composition comprising the salt. Further provided is a use thereof in the preparation of a medicament for treating and preventing diseases related to PI3K kinase abnormalities.
Inventors:
XI NING (CN)
LI XIAOBO (CN)
LI MINXIONG (CN)
FENG XUEJIN (CN)
LI XIAOBO (CN)
LI MINXIONG (CN)
FENG XUEJIN (CN)
Application Number:
PCT/CN2022/141345
Publication Date:
July 06, 2023
Filing Date:
December 23, 2022
Export Citation:
Assignee:
SUNSHINE LAKE PHARMA CO LTD (CN)
International Classes:
A61K31/517; C07D413/14; A61P9/10; A61P11/00; A61P31/12; A61P35/02; A61P37/00
Domestic Patent References:
| WO2019143874A1 | 2019-07-25 |
Foreign References:
| CN110003192A | 2019-07-12 | |||
| CN109516975A | 2019-03-26 | |||
| CN104447727A | 2015-03-25 |
Download PDF:
Previous Patent: COMMUNICATION METHOD AND RELATED DEVICE
Next Patent: ORGANIC COMPOUND AND USE THEREOF
Next Patent: ORGANIC COMPOUND AND USE THEREOF